財務情報
- Market Capitalization 11.38 B
- Employee 3 000
- Founded 1976
- CEO Kim Kelderman
- Website www.bio-techne.com
- Headquarter Minnesota, United States
- FIGI BBG000C15114
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
60.91
売上高対価格比率
9.13
1株当たり配当金
0.32
配当利回り(%)
0.45
関連ティッカー
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 795 | CORT Corcept Therapeutics Incorporated - Common Stock | 110.16 USD | -2.83% | -9.11% | -0.12% | +50.14% | 11.91 B USD | ||
| 806 | SMMT Summit Therapeutics Inc. - Common Stock | 14.63 USD | -4.81% | -15.63% | -20.58% | -26.33% | 11.67 B USD | ||
| 855 | BMRN BioMarin Pharmaceutical Inc. - Common Stock | 54.68 USD | -2.44% | -0.58% | -15.03% | +2.49% | 10.58 B USD | ||
| 863 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 449.74 USD | -2.19% | -4.67% | -16.10% | +6.17% | 10.39 B USD |